1945
DOI: 10.1001/archotol.1945.00680040033004
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Acetylsalicylic Acid, a Probable Cause for Secondary Post-Tonsillectomy Hemorrhage: A Preliminary Report

Abstract: The post-tonsillectomy healing process is characterized by a reactive inflammation with healing by second intention. As a clinical complication, bleeding, sometimes of a dangerous nature, may occur. This postoperative hemorrhage is classified as either primary or secondary. The former, rarely encountered, arises within the first twenty-four hours after operation and originates from a small spurting artery or a small oozing vein; the latter occurs three to ten days postoperatively and is of the parenchymatous t… Show more

Search citation statements

Order By: Relevance

Paper Sections

Select...
35
1
0
0

Citation Types

0
8
0
1

Year Published

1946
1946
2022
2022

Publication Types

Select...
33
2
1

Relationship

0
36

Authors

Journals

citations

Cited by 36 publications

(9 citation statements)
references

References 6 publications

0
8
0
1
Order By: Relevance
How this paper cites the one you are viewing
“…Acetylsalicylic acid may cause excessive bleeding during and after surgery (9,20,22), it may promote epistaxis (17), and haemorrhagic complications seem to be more frequent in the newborn infants of women who have ingested acetylsalicylic acid during the last week of pregqancy (4). The effects of the drug o n haemostasis are multiple.…”
Section: Discussion
mentioning
confidence: 99%
How this paper cites the one you are viewing
“…Acetylsalicylic acid may cause excessive bleeding during and after surgery (9,20,22), it may promote epistaxis (17), and haemorrhagic complications seem to be more frequent in the newborn infants of women who have ingested acetylsalicylic acid during the last week of pregqancy (4). The effects of the drug o n haemostasis are multiple.…”
Section: Discussion
mentioning
confidence: 99%
How this paper cites the one you are viewing
“…Podría asumirse que el camino al uso de la aspirina como antiagregante plaquetario se inició desde 1945, cuando en la literatura médica mundial se informó, una vez más, el riesgo hemorrágico por el consumo de la aspirina [30][31][32], especialmente, cuando se empezó a observar en pacientes sometidos a amigdalectomía [33], a quienes se les practicaban extracciones dentales [34] y a nivel gastrointestinal [35]. Inicialmente, las manifestaciones hemorrágicas fueron erróneamente atribuidas a una alteración en el tiempo de protrombina [36], hasta 1948, cuando Paul Gibson, en Inglaterra, sugirió que el ácido acetilsalicílico podría ser útil en el tratamiento de la trombosis coronaria [37] y al año siguiente presentó informes de casos que detallaban el papel de la aspirina en el tratamiento de la trombosis coronaria y de la angina de pecho [38].…”
Section: La Aspirina Como Antiagregante Plaquetario
unclassified
How this paper cites the one you are viewing
“…Clinically, this can result in easy bruisability in patients taking aspirin or aspirin-containing products, as well as significant bleeding following minor or major surgical procedures. Its use has been implicated as a probable cause of post-tonsillectomy hemorrhage and bleeding following tooth extractions [89]. The effect on hemostasis may be disproportionately greater in patients with bleeding disorders such as hemophilia, von Willebrand's disease or afibrinogenemia [90].…”
Section: Impairment Of Hemostasis
mentioning
confidence: 99%